
"Marlboro Maker's $2 Billion Medicine Bet Gets a Reset"
Marlboro maker, Philip Morris International, is reportedly hitting the reset button on its $2 billion bet on medicine, as the company faces challenges in gaining regulatory approval for its smoke-free products. The company had invested heavily in developing inhalable drugs and devices, but is now shifting its focus to other areas such as nicotine pouches and heated tobacco products.

